MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2024
Medivir brings the Q1 webcast forward to 10 a.m. on April 30
Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI
Quarterly report presentations
Annual General Meeting 2024
Redeye Growth Day
Redeye Life Science Day
Medivir Corporate Governance documention.
Documentation from Medivir's Annual General Meetings.